InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Grant Papanek Julie, Director. Director active across 1 company, notably Day One Biopharmaceuticals, Inc.. Aggregated, 8 disclosures have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €435k. History available since 1 July 2022. The latest transaction was disclosed on 2 September 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Grant Papanek Julie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
5,000 shares@ US$23.821527.5% of flowCommon StockSEC:0001209191-22-050010:0
4,469 shares@ US$23.209423.9% of flowCommon StockSEC:0001209191-22-048899:0
5,000 shares@ US$20.000822.4% of flowCommon StockSEC:0001209191-22-044898:0
2,600 shares@ US$20.000411.8% of flowCommon StockSEC:0001209191-22-042764:0
1,242 shares@ US$20.005.6% of flowCommon StockSEC:0001209191-22-041984:0
1,000 shares@ US$20.004.4% of flowCommon StockSEC:0001209191-22-041994:0
1,000 shares@ US$20.004.4% of flowCommon StockSEC:0001209191-22-041408:0
7,328,497 sharesCommon StockSEC:0001209191-21-037460:0
8 of 8 declarations
About Grant Papanek Julie
Julie Grant Papanek is a Director at Day One Biopharmaceuticals, Inc. As a board member, she participates in the governance of the company and the development of its strategy. Day One Biopharmaceuticals is a biopharmaceutical company dedicated to discovering treatments for serious diseases. Julie Grant Papanek brings valuable expertise in the biopharmaceutical sector, enhancing the company's ability to innovate.
